WELCOME TO IDOI

Treating complex oncological cases often requires extraordinary and personalized measures. We use novel approaches to each particular case while in direct personal contact with the patient.

Mission

To attend isolated and complex cases of different types of cancer that require extraordinary measures through highly-effective techniques that do not deteriorate the clinical and immunological condition.

Vision

To be the global leaders in cancer treatments by improving the life quality of patients with negative diagnosis, employing the latest technological and scientific capabilities.

Values

Ethics, Honesty, Responsibility and Respect for life.

Our Work

The Super-selective Intra-Arterial Chemotherapy (SSIAC) program was formed as a result of our aim to tend for our patients quality of life and treating their cases in an individualized basis by providing them with the best possible service and care.

We offer SSIAC as an alternative treatment for various types of malignancies, including pancreatic, lung, prostate, breast, and brain cancer.

Our services include standard and compassionate treatments that can improve a patient's survival, quality of life, reducing cancer symptoms, while minimizing drug side effects.

IDOI is considered a leader in brain tumor treatment, and is renowned for controlling the disease in over 60 patients with Diffuse Intrinsic Pontine Glioma (DIPG), with increased overall survival and quality of life.

IDOI’s drugs, delivery methods, and procedures have been granted approval in different countries around the world as an option for, among others, retinoblastoma, bone and liver cancers (see publications).

Our Origin

The Instituto de Oncología Intervencionista is a multidisciplinary team officially founded in 2017 by doctors Alberto Jerónimo Siller Aguirre and José Alberto García de la Fuente after multiple instances of successful collaboration helping patients and giving hope back. Joining two successful professional careers and two complementary experiences, one focused on Oncology and the other on Interventional Neuroradiology, has allowed to find new ways of using multiple techniques, procedures, and medications to treat different types of cancer.

Team IDOI

IDOI is made up of a group of specialists and researchers in different areas such as Oncology, Interventionist Neuroradiology, Pediatrics, Interventional Pediatrics, Anesthesiology and Neurosurgery, among others.

Dr. Alberto Jerónimo Siller

Dr. Alberto Siller has a Bachelor of Surgery awarded by Universidad Autonoma de Nuevo Leon (UANL), Mexico, with a specialty in Pediatric Medicine and Pediatric Hematology also awarded by UANL in 1986 and 1987, respectively; a speciality in Hematology and Pediatric Oncology by the University of California in Los Angeles, U.S.A. in 1991; and he studied Hematopoietic Progenitor Cellular Transplant at the Saint Joseph Hospital of Orange County California, also in the United States, in 1992.

Alberto actively participates in diverse national and international congresses, such as the National Confederation of Pediatrics of Mexico (CONAPEME), the Northeastern Pediatric Federation (Federacion Noreste de Pediatria), and the Pediatric School of the State of Coahuila (Colegio de Pediatras del Estado de Coahuila), as well as those organized by the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).

Throughout his career, Dr. Siller has been part of Centro Medico Nacional del Norte, Hospital San Jose Tec de Monterrey, Christus Muguerza, Oca Hospital and Doctors Hospital in the services of Hematology and Pediatric Oncology, as well as in the Transplantation of Hematopoietic Progenitor Cells.

His scientific interest motivated him to act as director of the Cellular and Molecular Investigation Laboratory of Oca Hospital.

He is also coauthor of articles published in journals such as: Blood, Haematologica y J. Hematother Stem Cell.

Dr. Alberto García de la Fuente

Dr. Alberto García has a degree in Medicine, awarded by Universidad Autonoma de Ciudad Juarez, Chihuahua, Mexico; a Radiology specialty in 1988 and a subspecialty in Neuroradiology by the National Neurology and Neurosurgery Institute (INNN), and in Endovascular Therapy by the Lariboisiere Hospital, in Paris, France, in 1990 and 1992, respectively; and a Master’s Degree in Bioethics awarded by Universidad de Monterrey (UDEM).

Dr. Garcia de la Fuente is author of various articles in medical publications such as Neurosurgery Magazine, Surgery and Surgeon Magazine (Revista Cirugía y Cirujanos), the Mexican Radiology Magazine (Revista Mexicana de Radiologia) and the National Neurology and Neurosurgery Institute Magazine (Revista del Instituto Nacional de Neurologia y Neurocirugia, INNN).

Alberto's medical work has been recognized numerous times in national and international congresses, in which he participates actively. In 1994 he received the award for best free work presented in the Annual Congress of the Mexican Society of Neurology (Congreso Anual de la Sociedad Mexicana de Neurologia), granted by Serono de Mexico. Two years later, he received the best free work award in the Annual Reunion of the Mexican Diagnostic and Therapeutic Neuroradiology Mexican Society (SMNR).

Also, in 1996, during the Ibero Latin American Diagnostic and Therapeutic Neuroradiology Society Congress (SILAN) in Caracas, Venezuela he received the best free work award in Endovascular Therapy.

Throughout his trajectory, Dr. García has occupied distinguished positions, such as Appointed Medic of the Neurology and Neurosurgery National Institute of the Children’s Hospital of Mexico (INNN), as well as the Department of Radiology and Image of Hospital Angeles del Pedregal in Mexico City. He has also served as the Head of the Hemodinamia and Intervention Department of Hospital José A. Muguerza in Monterrey, Nuevo Leon.

He shares his knowledge with different hospitals in the country, where he is adviser and consulting medic on Endovascular Therapy.